14TH ISOPT CLINICAL: INTERNATIONAL SYMPOSIUM ON OCULAR PHARMACOLOGY & THERAPEUTICS
Tel Aviv CinemathequeTEL AVIV, ISRAEL Visit the Venue to read more
It is our great pleasure welcoming you to the 14th ISOPT Clinical meeting in Tel Aviv, Israel.
This year's meeting will focus on drugs and devices as part of the ophthalmologist tool box dealing with ailments of the eye. Ophthalmology had been traditionally a surgical field. Over the last decades a slow, but significant revolution took place with the introduction of new drugs utilizing invasive modes of delivery to the eye. In addition, new devices and drug/device combinations are being launched and change the way we practice ophthalmology today.
The vision of ISOPT Clinical had evolved since 1995 centering on:
Increasing knowledge and awareness of drug utilization in ophthalmology
Reflecting innovations and their application in daily practice
Bridging the present to the future
This will be reflected in ISOPT Clinical mission:
Discussion of treatment algorithms in major ophthalmic indications
Implement data from clinical studies for daily practice
Facilitate innovation – connecting innovators with clinicians
Encourage meetings of young innovators with the pharma industry
ISOPT Clinical offers a relevant and updated scientific program in a relaxed atmosphere leading to direct interactions of its delegates. We are sure that Interaction with colleagues from many different countries will stimulate a creative exchange of ideas and will be personally rewarding.
We welcome you to Tel Aviv,
Sara Krupsky, MD
B. D. Kuppermann, USA
Special Program Advisor
B. Katz, USA
R. Neumann, Israel
Inflammation & Infection Section
Registration fees include: meeting kit, program handouts, admittance to scientific sessions, certificate of attendance, light lunch on session days and coffee/refreshments at breaks.
*Proof of status is required at the time of registration
**Eastern European Delegates and Trainees must live and work in one of the following countries:
Albania, Armenia, Azerbaijan, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, The Czech Republic, Estonia, Georgia, Hungary, Kosovo, Latvia, Lithuania, Montenegro, F.Y.R. Macedonia, Moldova, Poland, Romania, Russia, Serbia, Slovakia, Slovenia and Ukraine.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
Target Conferences is the official travel agent for the Symposium, and will be offering special reduced rates for accommodation.
Hotel space has been blocked by Target Conferences, on a bed and breakfast basis, at the following hotels
The organizers are pleased to announce a call for abstracts for oral and poster presentation.
All submitted abstracts will be reviewed for acceptance based on their scientific merit.
Kindly specify if you would prefer an oral or poster presentation on the online submission form. The authors will be informed in due time whether their abstracts have been accepted, and whether for oral or poster presentation.
Inclusion of abstracts in the scientific program is dependent on payment of registration fees.
The Organizers welcome abstract submissions for poster and oral presentations on the topics that are listed, but not limited to, those mentioned:
Current and future ocular drug therapy:
Cornea & Ant. Segment diseases
Innovation in Ophthalmology
Abstracts must be submitted using the on-line submission link. Please do not fax, mail or email your abstracts as they will not be considered.
All abstracts must be submitted in English.
The names and affiliations of all authors should be included in the abstract.
Abstracts should be no longer than 280 words (excluding title and affiliations).
Abstract submission deadline 2017-11-20
A commercial exhibition will take place within the framework of the Symposium.
Exhibit Space Rates:
Standard 4 sqm area: €2000
Additional €500 per sqm
Company logo on the event website and final Program
Standard booth construction
Two complimentary exhibitor registrations per standard space purchased
ISOPT Clinical is the meeting focusing on ocular treatments with drugs & devices and brings together clinicians, clinical investigators, academy based researchers and members of the industry. A major theme of the 2018 ISOPT Clinical Symposium will be the translation of phase 3 data to "real world" medical practice.
The importance of collaboration between science and industry is reflected in the content of the meeting program (Previous programs). You are invited to join both as a sponsor and as an expert in ocular drug development and take part in the discussions.
If you wish to bring to the front research and development on a topic of interest to your company or present a product ready for the market, you may choose to plan a 45 minutes company sponsored session.
You may also attract the attention to your presence in the ophthalmic market by other modes of sponsorship and educational grants.
For details please contact:
Katia Papkov , Meeting Secretariat , Target Conferences Ltd.